Aggeler R, Mendel-Hartvig J, Capaldi R A
Institute of Molecular Biology, University of Oregon, Eugene 97403.
Biochemistry. 1990 Nov 13;29(45):10387-93. doi: 10.1021/bi00497a013.
Monoclonal antibodies (mAbs) have been made against each of the five subunits of ECF1 (alpha, beta, gamma, delta, and epsilon), and these have been used in topology studies and for examination of the role of individual subunits in the functioning of the enzyme. All of the mAbs obtained reacted with ECF1, while several failed to react with ECF1F0, including three mAbs against the gamma subunit (gamma II, gamma III, and gamma IV), one mAb against delta, and two mAbs against epsilon (epsilon I and epsilon II). These topology data are consistent with the gamma, delta, and epsilon subunits being located at the interface between the F1 and F0 parts of the complex. Two forms of ECF1 were used to study the effects of mAbs on the ATPase activity of the enzyme: ECF1 with the epsilon subunit tightly bound and acting to inhibit activity and ECF1* in which the delta and epsilon subunits had been removed by organic solvent treatment. ECF1* had an ATPase activity under standard conditions of 93 mumol of ATP hydrolyzed min-1 mg-1, cf. an activity of 7.5 units mg-1 for our standard ECF1 preparation and 64 units mg-1 for enzyme in which the epsilon subunit had been removed by trypsin treatment. The protease digestion of ECF1* reduced activity to 64 units mg-1 in a complicated process involving an inhibition of activity by cleavage of the alpha subunit, activation by cleavage of gamma, and inhibition with cleavage of the beta subunit. mAbs to the gamma subunit, gamma II and gamma III, activated ECF1 by 4.4- and 2.4-fold, respectively, by changing the affinity of the enzyme for the epsilon subunit, as evidenced by density gradient centrifugation experiments. The gamma-subunit mAbs did not alter the ATPase activity of ECF1*- or trypsin-treated enzyme. The alpha-subunit mAb (alpha I) activated ECF1 by a factor of 2.5-fold and ECF1F0 by 1.3-fold, but inhibited the ATPase activity of ECF1* by 30%.
已经制备了针对ECF1五个亚基(α、β、γ、δ和ε)中每一个的单克隆抗体(mAb),这些抗体已用于拓扑学研究以及研究单个亚基在酶功能中的作用。获得的所有单克隆抗体都与ECF1反应,而有几种未能与ECF1F0反应,包括三种针对γ亚基的单克隆抗体(γ II、γ III和γ IV)、一种针对δ亚基的单克隆抗体以及两种针对ε亚基的单克隆抗体(ε I和ε II)。这些拓扑学数据与γ、δ和ε亚基位于复合物F1和F0部分之间的界面处一致。使用两种形式的ECF1来研究单克隆抗体对酶ATPase活性的影响:一种是ε亚基紧密结合并抑制活性的ECF1,另一种是通过有机溶剂处理去除了δ和ε亚基的ECF1*。在标准条件下,ECF1的ATPase活性为每毫克每分钟水解93微摩尔ATP,相比之下,我们标准的ECF1制剂的活性为每毫克7.5单位,而经胰蛋白酶处理去除了ε亚基的酶的活性为每毫克64单位。ECF1的蛋白酶消化在一个复杂的过程中将活性降低到每毫克64单位,该过程涉及通过α亚基的切割抑制活性、通过γ亚基的切割激活活性以及通过β亚基的切割抑制活性。针对γ亚基的单克隆抗体γ II和γ III分别通过改变酶对ε亚基的亲和力使ECF1激活了4.4倍和2.4倍,密度梯度离心实验证明了这一点。γ亚基单克隆抗体不会改变ECF1或经胰蛋白酶处理的酶的ATPase活性。α亚基单克隆抗体(α I)使ECF1激活了2.5倍,使ECF1F0激活了1.3倍,但使ECF1的ATPase活性降低了30%。